The data is clear by now: Booster doses are providing high levels of protection against the misery caused by the coronavirus.
Pfizer expects to make $36 billion from its covid-19 vaccine in 2021 alone.
Essential workers traveling from Mexico and Canada still have a couple of months to get vaccinated.
Facebook will also roll out reminders about how the vaccine is now available and where to get it.
In a clinical trial, Pfizer/BioNTech's vaccine was estimated to be 90% effective at preventing the viral illness in children.
For those who need boosters, the mix-and-match approach with the various vaccines seems to be safe and effective.
High-risk Americans and those over 65 are being told to get boosters, while J&J recipients should get any shot they want two months after their original dose.
The panel agreed that people over 65 and high-risk groups who took the original Moderna vaccine should be able to get a half-strength booster.
Just 7% of Africans have gotten at least one dose of covid-19 vaccine, compared to 57% of Europeans.
Starting Monday, visitors 12 and above must show vaccination cards or a negative covid-19 test taken within 72 hours of visiting.
The agency said booster shots can be given to individuals at least six months after they receive their first 2-dose series and any time after that.
The trial data, yet to be seen by outside scientists, will be soon submitted to regulators to win authorization of the vaccine for children in this age group.
The meeting featured hours of discussion and a cameo by Nicki Minaj's cousin's friend's genital issues.
New findings could influence an upcoming decision by U.S. health experts on who will need booster doses.
Research found that around 5% of vaccinated people with a confirmed infection still had symptoms 28 days or more later, compared to 11% of unvaccinated.
Officials and experts affiliated with the FDA and CDC might not be as gung-ho about recommending boosters for everyone next month as the White House is.
In real-world data from Israel, adverse events like heart inflammation were much more common in infected people than those vaccinated with the Pfizer shot.
Data continues to show that the vaccinated face a far lower risk of hospitalization and death.
The FDA says the shot is now fully approved for people 16 and older.
A small study found that survivors of the original SARS outbreak created especially potent antibodies after they were fully vaccinated against SARS-CoV-2.
